ScholarLens Back to search
2006•Hebei yixueRequires access

Clinical Value of CT-Guided Percutaneous Transthoracic Needle Aspiration Biopsy

Jie Yang

Open publisher page 0 citations

Abstract

Objective: To evaluate the clinical value of CT-guided percutaneous transthoracic needle aspiration biopsy.Method: Retrospectly study on 112 patients undergoing CT-guided percutaneous transthoracic needle aspiration biopsy,94 of which were diagnosed by pathology.Result: 86 out of 94 patients were proved malignant lung cancer,among which 78 cases were through CT-guided percutaneous transthoracic needle aspiration.The other 8 of 94 patients were proved benign.The diagnositic sensitivity,specificity and accuracy went up to,respectively,90.7%,100% and 91.5%.The incidence percentage of pneumothroax and hemorrhage were 8.9% and 10.7%.Conclusion: CT-guided percutaneous transthoracic needle aspiration biopsy is a safe and accurate method in the diagnosis and differential diagnosis of lung mass,which enjoys high clinical value.

About this research paper

What this paper is about

Objective: To evaluate the clinical value of CT-guided percutaneous transthoracic needle aspiration biopsy.Method: Retrospectly study on 112 patients undergoing CT-guided percutaneous transthoracic needle aspiration biopsy,94 of which were diagnosed by pathology.Result: 86 out of 94 patients were proved malignant lung cancer,among which 78 cases were through CT-guided percutaneous transthoracic needle aspiration.The other 8 of 94 patients were proved benign.The diagnositic sensitivity,specificity and accuracy went up to,respectively,90.7%,100% and 91.5%.The incidence percentage of pneumothroax and hemorrhage were 8.9% and 10.7%.Conclusion: CT-guided percutaneous transthoracic needle aspiration biopsy is a safe and accurate method in the diagnosis and differential diagnosis of lung mass,which enjoys high clinical value.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the clinical value of CT-guided percutaneous transthoracic needle aspiration biopsy.Method: Retrospectly study on 112 patients undergoing CT-guided percutaneous transthoracic needle aspiration biopsy,94 of which were diagnosed by pathology.Result: 86 out of 94 patients were proved malignant lung cancer,among which 78 cases were through CT-guided percutaneous transthoracic needle aspiration.The other 8 of 94 patients were proved benign.The diagnositic sensitivity,specificity and accuracy went up to,respectively,90.7%,100% and 91.5%.The incidence percentage of pneumothroax and hemorrhage were 8.9% and 10.7%.Conclusion: CT-guided percutaneous transthoracic needle aspiration biopsy is a safe and accurate method in the diagnosis and differential diagnosis of lung mass,which enjoys high clinical value.

Key concepts: Medicine, Percutaneous, Radiology, Biopsy, Lung cancer, Fine-needle aspiration, Incidence (geometry), Internal medicine

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Clinical Value of CT-Guided Percutaneous Transthoracic Needle Aspiration Biopsy — Research Paper | ScholarLens